AVROBIO INC (AVRO)

US05455M1009 - Common Stock

1.21  +0.02 (+2.11%)

Fundamental Rating

3

Taking everything into account, AVRO scores 3 out of 10 in our fundamental rating. AVRO was compared to 588 industry peers in the Biotechnology industry. While AVRO has a great health rating, there are worries on its profitability. AVRO has a expensive valuation and it also scores bad on growth.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

AVRO had negative earnings in the past year.
AVRO had a negative operating cash flow in the past year.
AVRO had negative earnings in 4 of the past 5 years.
AVRO had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With an excellent Return On Assets value of 12.02%, AVRO belongs to the best of the industry, outperforming 97.77% of the companies in the same industry.
AVRO has a better Return On Equity (12.83%) than 96.75% of its industry peers.
Industry RankSector Rank
ROA 12.02%
ROE 12.83%
ROIC N/A
ROA(3y)-49.45%
ROA(5y)-45.78%
ROE(3y)-65.96%
ROE(5y)-56.84%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AVRO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

7

2. Health

2.1 Basic Checks

The number of shares outstanding for AVRO has been increased compared to 1 year ago.
The number of shares outstanding for AVRO has been increased compared to 5 years ago.
There is no outstanding debt for AVRO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -2.71, we must say that AVRO is in the distress zone and has some risk of bankruptcy.
AVRO has a Altman-Z score (-2.71) which is in line with its industry peers.
AVRO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.71
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

AVRO has a Current Ratio of 15.78. This indicates that AVRO is financially healthy and has no problem in meeting its short term obligations.
AVRO's Current ratio of 15.78 is amongst the best of the industry. AVRO outperforms 91.61% of its industry peers.
A Quick Ratio of 15.78 indicates that AVRO has no problem at all paying its short term obligations.
AVRO's Quick ratio of 15.78 is amongst the best of the industry. AVRO outperforms 91.61% of its industry peers.
Industry RankSector Rank
Current Ratio 15.78
Quick Ratio 15.78

More info and screens

1

3. Growth

3.1 Past

AVRO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.44%, which is quite impressive.
EPS 1Y (TTM)34.44%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q64.91%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A

3.2 Future

AVRO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.25% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y69.01%
EPS Next 2Y33.56%
EPS Next 3Y25.45%
EPS Next 5Y16.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AVRO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AVRO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as AVRO's earnings are expected to grow with 25.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.56%
EPS Next 3Y25.45%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AVRO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVROBIO INC

NASDAQ:AVRO (4/26/2024, 7:00:00 PM)

1.21

+0.02 (+2.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap54.28M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.02%
ROE 12.83%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 15.78
Quick Ratio 15.78
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)34.44%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y69.01%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y